Small Cell Lung Cancer: Results of a Phase II Study of 1,2,4-Triglycidylurazol

    David Cunningham, S. W. Banham, M. Soukop
    Image
    Studysummary The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →